About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Dark Matter of Human Genome Sheds Light on Prostate Cancer Challenge

by Colleen Fleiss on May 29, 2018 at 1:47 AM
Font : A-A+

Dark Matter of Human Genome Sheds Light on Prostate Cancer Challenge

Single lncRNA named ARLNC1 provided insight into a key driver of prostate cancer - and a potential target for future therapy.

Researchers at the Knocking down this long non-coding RNA in mice led to cancer cell death, suggesting this may be a key target for future therapies, said University of Michigan Rogel Cancer Center researchers. The study is published in Nature Genetics.

Advertisement


Current prostate cancer treatments aim to block the androgen receptor to stop cancer growth. But most patients become resistance to androgen-specific therapies, developing a challenging form of the disease called metastatic castration-resistant prostate cancer. "The androgen receptor is an important target in prostate cancer. Understanding that target is important. This study identifies a feedback loop that we could potentially disrupt as an alternative to blocking the androgen receptor directly," says study senior author Arul Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology.

Chinnaiyan's lab identified thousands of lncRNAs in a 2015 paper. Long non-coding RNAs are considered the dark matter of the genome because so little is known about them. While searching for lncRNAs that might play a role in prostate cancer, the team discovered that ARLNC1 is elevated in prostate cancer relative to benign prostate tissue, which suggests a role in cancer development. And it was associated with androgen receptor signaling, which made it more intriguing.
Advertisement

The researchers found that the androgen receptor actually induces ARLNC1 expression. Then ARLNC1 binds to the androgen receptor messenger RNA transcript. This stabilizes the level of androgen receptor, which then feeds back to sustain ARLNC1. "At the end of the day, you're creating or stabilizing more androgen receptor signaling in general and driving this oncogenic pathway forward. We're envisioning a potential therapy against ARLNC1 in combination with therapy to block the androgen receptor - which would hit the target and also this positive feedback loop," Chinnaiyan says.

When researchers blocked ARLNC1 in cell lines expressing androgen receptor, it led to cancer cell death and prevented tumor growth. In mouse models, elevating ARLNC1 caused large tumors to form. Knocking down ARLNC1 in mice caused tumors to shrink. Researchers plan to continue studying the biology of ARLNC1 to understand how it's involved in prostate cancer progression and androgen receptor signaling.

"We want to further characterize the dark matter of the genome," Chinnaiyan says. "There are a number of these lncRNAs that we don't understand how they functionally work. Some of them will certainly be very useful as cancer biomarkers and we think a subset are important in biological processes."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Genetic Testing of Diseases Cancer Tattoos A Body Art Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] 

Recommended Reading
Decipher Test for Prostate Cancer
Decipher test a genomic test for prostate cancer that determines the aggressiveness of the cancer .....
Drugs for Prostate Cancer
Prostate cancer is the main cause of cancer death in men. One of the treatment method includes ......
Quiz on Prostate Cancer
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its ......
Prostate Cancer - Animation
Interactive section of Medindia gives details regarding Prostate Cancer...
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laborat...
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemothe...
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commo...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)